Bharat Immunological & Biologicals Corporation Ltd. - Research Center
524663 BIBCL Group (B) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Mar ' 21 | |
|---|---|---|---|---|---|
| Sales | - | 36.96 | 39.47 | 38.92 | 40.82 |
| Operating profit | -9.00 | -7.33 | -2.53 | -2.45 | -17.00 |
| Interest | 3.81 | 3.32 | 3.21 | 2.38 | 2.52 |
| Gross profit | -12.55 | -10.19 | -5.10 | -4.37 | -17.40 |
| EPS (Rs) | -2.20 | -1.87 | -0.31 | -1.72 | -3.12 |
Half yearly
results in details
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Mar ' 21 | |
|---|---|---|---|---|---|
| Other income | 0.27 | 0.46 | 0.64 | 0.47 | 2.12 |
| Stock adjustment | - | 5.95 | 4.48 | -4.03 | 24.32 |
| Raw material | - | 26.52 | 24.34 | 34.84 | 19.83 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 7.88 | 7.90 | 7.96 | 5.89 | 9.39 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 1.13 | 3.92 | 5.22 | 4.67 | 4.28 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.07 | 0.07 | 0.10 | 0.12 | 0.12 |
| Taxation | -3.11 | -2.18 | -3.88 | 2.95 | -4.06 |
| Net profit / loss | -9.51 | -8.08 | -1.32 | -7.43 | -13.46 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 43.18 | 43.18 | 43.18 | 43.18 | 43.18 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | - | -19.83 | -6.41 | -6.30 | -41.65 |
| GPM (%) | - | -27.23 | -12.73 | -11.10 | -40.52 |
| NPM (%) | - | -21.59 | -3.29 | -18.87 | -31.35 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis